# Neuromuscular Blockade for Optimising Surgical Conditions During Spinal Surgery

> **NCT02778945** · PHASE4 · UNKNOWN · sponsor: **The Catholic University of Korea** · enrollment: 60 (estimated)

## Conditions studied

- Neuromuscular Block
- Orthopedic Disorder of Spine
- Muscle Weakness

## Interventions

- **DRUG:** Rocuronium 0.9 mg/kg
- **DRUG:** Rocuronium 0.6 mg/kg

## Key facts

- **NCT ID:** NCT02778945
- **Lead sponsor:** The Catholic University of Korea
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-09-01
- **Primary completion:** 2019-03-28
- **Final completion:** 2019-05-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2019-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02778945

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02778945, "Neuromuscular Blockade for Optimising Surgical Conditions During Spinal Surgery". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02778945. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*